Malignant gliomas consist of glioblastomas, anaplastic astrocytomas, anaplastic
oligodendrogliomas and anaplastic oligoastrocytomas, and some less common tumors such …

Purpose Treatment and prognosis of gliomas depend on their histological tumour grade.
The aim of the study was to evaluate the potential of [18 F] fluoroethyltyrosine (FET) PET for …

The aim of this study was to investigate the potential of O-(2-18F-fluoroethyl)-l-tyrosine (18F-
FET) PET for differentiating local recurrent brain metastasis from radiation necrosis after …

Purpose To investigate prospectively the potential of O-(2-[18 F] fluoroethyl)-l-tyrosine (18 F-
FET) PET in comparison to MRI for the assessment of the response of patients with recurrent …

The aim of the present study was to evaluate whether extended analyses of O-(2-18F-
fluoroethyl)-l-tyrosine (FET) uptake kinetics provide results superior to those of standard …

Full article: Antiangiogenic therapy for patients with glioblastoma: current challenges in imaging
and future directions Skip to Main Content Taylor and Francis Online homepage Taylor and …

BACKGROUND: The authors evaluated a 3‐week schedule of bevacizumab in patients with
recurrent high‐grade glioma (HGG). METHODS: Patients received bevacizumab 15 mg/kg …

Survival for glioblastoma (GBM) patients with an unmethyated MGMT promoter in their tumor
is generally worse than methylated MGMT tumors, as temozolomide (TMZ) response is …

Bevacizumab is used to treat glioblastoma; however, no current biomarker predicts its
efficacy. We used an exploratory cohort of patients treated with the radiochemotherapy then …

Methods: We examined these parameters in GBM specimens from 50 adult patients; referred
to Al-Zahra hospital Pathology Lab between 2001 to 2006. These patients did not receive …